Release Date: 15/05/23 09:22 Summary: Creso Pharma Expands Asia Market Footprint Price Sensitive: No Download Document 370.99KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%